Yicong Liang

Yicong Liang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yicong Liang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Zhen Luo

    Institute of Medical Microbiology, Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China

    3 shared publications
  • Chengcheng Li

    Modern Chinese Literature, Department of Chinese Language and Literature, Peking University, Beijing 100871, China

    1 shared publication
  • Chengcheng Li

    Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China

    1 shared publication
  • Fang Wang

    Department of Infectious Diseases, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, China

    1 shared publication
  • Fanpeng Zhao

    Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, USA

    1 shared publication
  • Haonan Zhang

    State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, 430062, Wuhan, China; Hubei Jiangxia Laboratory, 430200, Wuhan, China

    1 shared publication

Latest Publications

  • Open Access

    Enterovirus A71 exploits peripheral circulating extracellular vesicles to facilitate blood-brain barrier permeability

    by Yicong Liang, Yi Meng, Yue Kong, Shanyu Huang, Zhaoyang Zhou, Shuang Liu, Xing Zhou, Fanpeng Zhao, Fang Wang, Zhipeng Jin, et al.

  • Open Access

    Umbilical Cord Mesenchymal-Stem-Cell-Derived Exosomes Exhibit Anti-Oxidant and Antiviral Effects as Cell-Free Therapies

    by Yi Meng, Chengcheng Li, Yicong Liang, Yu Jiang, Haonan Zhang, Jianhua Ouyang, Wen Zhang, Rumei Deng, Qiuping Tan, Xiaolan Yu, et al.

    The oxidative stress induced by the accumulation of reactive oxygen species (ROS) can lead to cell aging and death. Equally, the skeletal muscle usually hosts enteroviral persistent infection in inflammatory muscle diseases. As excellent bioactive products, the exosomes derived from umbilical cord mesenchymal stem cells (ucMSCs) have been proven to be safe and have low immunogenicity with a potential cell-free therapeutic function. Here, exosomes derived from ucMSCs (ucMSC-EXO) were extracted and characterized. In a model of oxidative damage to skin fibroblasts (HSFs) under exposure to H2O2, ucMSC-EXO had an observable repairing effect for the HSFs suffering from oxidative damage. Furthermore, ucMSC-EXO inhibited mitogen-activated protein kinases (MAPK), c-Jun N-terminal kinase (JNK), and nuclear factor kappa-B (NF-κB) signaling pathways, thereby promoting p21 protein expression while decreasing lamin B1 protein expression, and finally alleviated oxidative stress-induced cell damage and aging. In a model of rhabdomyosarcoma (RD) cells being infected by enterovirus 71 (EV71) and coxsackievirus B3 (CVB3), the ucMSC-EXO enhanced the expression of interferon-stimulated gene 15 (ISG15) and ISG56 to inhibit enteroviral replication, whereafter reducing the virus-induced proinflammatory factor production. This study provides a promising therapeutic strategy for ucMSC-EXO in anti-oxidative stress and antiviral effects, which provides insight into extending the function of ucMSC-EXO in cell-free therapy.


  • Open Access

    Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to boost exosome biogenesis to facilitate viral replication

    by Zhihui Ruan, Yicong Liang, Zicong Chen, Jialing Yin, Chengcheng Li, Pan Pan, Qiwei Zhang, Jianguo Wu, Zhen Luo

    Human enterovirus 71 (EV71) is one of the major agents of the hand, foot, and mouth disease (HFMD), and occasionally causes severe neurological complications. There is clinical evidence that EV71 infection increases the exosomes in the serum of severe HFMD patients, suggesting a role of exosomes in EV71 pathogenesis. However, the relationship between exosomes and EV71 replication remains elusive. In this study, we initially found that EV71 infection elevated exosome biogenesis in the cultured cells. Among EV71 non-structural proteins, we identified EV71 3A, but not 3B, constitutively promoted exosome secretion. In detail, EV71 3A protein interacted with vacuolar protein sorting 25 (VPS25), while knock-down of VPS25 reduced EV71 3A protein- and EV71-induced exosome production. Further studies revealed VPS25 located on exosomes and its expression correlated to the exosome production. During EV71 infection, knock-down of VPS25 decreased exosome biogenesis to attenuate viral replication. Consistently, GW4869, an exosome inhibitor, exerted an obviously antiviral activity against EV71 replication companied with the decrease of exosome secretion or formation. These findings suggest the binding of EV71 3A and VPS25 benefited exosome biogenesis, thereby boosting viral replication. This study uncovers a novel mechanism underlying EV71-mediated exosomes in the regulation of viral replication, which provides potential anti-viral strategies against the EV71 infection and transmission in HFMD.